Literature DB >> 36180706

Real-Time Monitoring of Circadian Rhythms in the Eye.

Kenkichi Baba1, Gianluca Tosini2.   

Abstract

The mammalian eye harbors a full circadian system that controls several physiologically relevant functions within this organ. During the last two decades a few laboratories have developed transgenic animal models in which circadian rhythms can be monitored in real time using luciferase activity. The most famous transgenic mouse to record bioluminescence rhythms from different tissues and organs is the PERIOD2::LUCIFERASE (PER2::LUC) mouse developed by the Takahashi laboratory in early 2000. Since then, several studies have used this mouse model to dissect the mammalian circadian system by monitoring the circadian rhythm in the brain, the eye, and in many other peripheral organs and tissues. This chapter describes the methodology to record and analyze bioluminescence rhythms from the retina, retinal pigment epithelium, and cornea of PER2::LUC mice.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Circadian rhythm; Ex vivo culture; Ocular physiology; PER2::LUC

Mesh:

Substances:

Year:  2022        PMID: 36180706     DOI: 10.1007/978-1-0716-2593-4_37

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors.

Authors:  Sherry L Winter; Lucine Bosnoyan-Collins; Dushanthi Pinnaduwage; Irene L Andrulis
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

2.  Circadian regulation of the PERIOD 2::LUCIFERASE bioluminescence rhythm in the mouse retinal pigment epithelium-choroid.

Authors:  Kenkichi Baba; Anamika Sengupta; Manfredi Tosini; Susana Contreras-Alcantara; Gianluca Tosini
Journal:  Mol Vis       Date:  2010-12-07       Impact factor: 2.367

Review 3.  Retinal Circadian Clocks are Major Players in the Modulation of Retinal Functions and Photoreceptor Viability.

Authors:  Christopher DeVera; Kenkichi Baba; Gianluca Tosini
Journal:  Yale J Biol Med       Date:  2019-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.